Research programme: mRNA therapeutics - Alexion/Moderna TherapeuticsAlternative Names: ALXN 1540
Latest Information Update: 13 Jul 2016
At a glance
- Originator Alexion Pharmaceuticals; Moderna Therapeutics
- Class RNA
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Liver disorders